Ionis Pharmaceuticals: Q2 Earnings Snapshot
By AP News
Published - Aug 01, 2024, 11:04 AM ET
Last Updated - Aug 01, 2024, 11:04 AM EDT
CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Thursday reported a loss of $66 million in its second quarter.
The Carlsbad, California-based company said it had a loss of 45 cents per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
The drug discovery and development company posted revenue of $225 million in the period, also exceeding Street forecasts. Nine analysts surveyed by Zacks expected $147.5 million.
